Proteomics International showcased PromarkerD at the American Diabetes Association’s 81st...
Proteomics International Presents at APAC Symposia Series
Managing Director, Dr Richard Lipscombe presents “Emerging Mass Spectrometry Approaches To Cancer Biomarker Discovery and QA/QC for Characterising Biologics” at invitation only events in Taipei (27th June), Seoul (29th June) and Tokyo (30th June).